Weibo Luo

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 
Google:
"Weibo Luo"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Luo M, Bao L, Xue Y, et al. (2024) ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2. The Journal of Clinical Investigation. 134
Bao L, Kumar A, Zhu M, et al. (2023) SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1. The Journal of Clinical Investigation. 133
Zhang B, Chen Y, Bao L, et al. (2022) GPT2 Is Induced by Hypoxia-Inducible Factor (HIF)-2 and Promotes Glioblastoma Growth. Cells. 11
Luo M, Bao L, Chen Y, et al. (2022) ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells. Science Advances. 8: eabn5295
Fang W, Liao C, Shi R, et al. (2021) ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer. Elife. 10
Wang Y, Chen Y, Wang C, et al. (2021) MIF is a 3' flap nuclease that facilitates DNA replication and promotes tumor growth. Nature Communications. 12: 2954
Chen L, Bao L, Niu Y, et al. (2020) LncIHAT is induced by hypoxia-inducible factor 1 and promotes breast cancer progression. Molecular Cancer Research : McR
Wang Y, Luo M, Chen Y, et al. (2020) ZMYND8 expression in breast cancer cells blocks T-lymphocyte surveillance to promote tumor growth. Cancer Research
Moore JA, Hubbi ME, Wang C, et al. (2020) Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the Gene. Journal of Investigative Medicine High Impact Case Reports. 8: 2324709620947256
Wang Y, Chen Y, Bao L, et al. (2020) CHD4 promotes breast cancer progression as a coactivator of hypoxia-inducible factors. Cancer Research
See more...